An Emergent Change in Epidemiologic and Microbiological Characteristics of Bloodstream Infections in Adults With Febrile Neutropenia Resulting From Chemotherapy for Acute Leukemia and Lymphoma at Reference Centers in Chile, Ecuador, and Peruarticle Published on 2024-03-012024-09-05 Journal: Open Forum Infectious Diseases [Category] update2024, [키워드] bloodstream infection febrile neutropenia gram-negative rods Multidrug resistance [DOI] 10.1093/ofid/ofae052 PMC 바로가기 [Article Type] article
Evaluating the cost-effectiveness of [ 18 F]FDG-PET/CT for investigation of persistent or recurrent neutropenic fever in high-risk haematology patientsarticle Published on 2023-12-152024-09-05 Journal: Cancer Imaging [Category] update2024, [키워드] antimicrobial cost-effectiveness Costing Diagnostic imaging febrile neutropenia [DOI] 10.1186/s40644-023-00647-7 PMC 바로가기 [Article Type] article
Epidemiology and source of infection in cancer patients with febrile neutropenia: an experience from a developing countryarticle Published on 2023-02-222024-09-05 Journal: BMC Infectious Diseases [Category] update2024, [키워드] antimicrobial resistance Cancer patients febrile neutropenia [DOI] 10.1186/s12879-023-08058-6 PMC 바로가기 [Article Type] article
Antibiotic Management of Patients with Hematologic Malignancies: From Prophylaxis to Unusual InfectionsReview Published on 2022-07-012023-07-08 Journal: Current oncology reports [Category] COVID19(2023년), [키워드] febrile neutropenia Hematologic diseases hematologic malignancies Immunocompromised infection diseases infections neutropenia Prophylaxis [DOI] 10.1007/s11912-022-01226-y PMC 바로가기 [Article Type] Review
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trialResearch article Published on 2021-11-092022-10-05 Journal: The Lancet. Oncology [Category] SARS, 임상, [키워드] 95% CI adverse event Against analysed Analysis antibody Antibody Response baseline benefit binding antibody unit Cancer cancer treatment Chemotherapy Cohort Complication Concentration COVID COVID-19 COVID-19 vaccination COVID-19 vaccine deaths defined develop development diarrhoea enrolled event febrile neutropenia Fever finding funding grade 3 histology IgG Immunotherapy increased risk individual individuals without cancer intramuscularly IQR margin median Moderna Most patient mRNA-1273 mRNA-1273 COVID-19 vaccine multicentre Netherland Netherlands non-inferiority design non-inferiority trial occurred Older participant Patient patient cohort patients per protocol positive Prevent primary endpoint receiving recorded Registered Safe SARS-COV-2 infection second vaccination Serious Adverse Event Seroconversion serum antibody response solid tumour Spain the primary endpoint the SARS-CoV-2 treated Trial Tumours vaccination Vaccine was done was used [DOI] 10.1016/S1470-2045(21)00574-X [Article Type] Research article
Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of researchCommentary Published on 2021-09-292022-10-31 Journal: Immunotherapy [Category] Coronavirus, SARS, [키워드] cancer patient Cancer patients COVID-19 Cytokine storm febrile neutropenia LIGHT Perspective proteomic profiling recombinant human granulocyte-colony stimulating factors (rhG-CSFs) Research [DOI] 10.2217/imt-2021-0219 PMC 바로가기 [Article Type] Commentary
Clinical presentation and outcomes of non-typhoidal Salmonella infections in patients with cancer암 환자에서 비장티푸스 살모넬라 감염의 임상 증상 및 결과Research Article Published on 2021-09-292024-07-29 Journal: BMC Infectious Diseases [Category] 살모넬라증, [키워드] Bacteremia febrile neutropenia foodborne diseases Immunocompromised host Salmonella infections Sepsis [DOI] 10.1186/s12879-021-06710-7 PMC 바로가기 [Article Type] Research Article
A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trialCOVID19에 감염된 종양-혈액학적 환자에서 호흡 부전 진행을 예방하기 위한 바리시티닙의 효능을 평가하기 위한 I/II상 임상 시험: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Letter Published on 2021-02-052022-09-10 Journal: Trials [Category] MERS, 임상, 치료제, [키워드] 1:1 AAK1 absence activator Acute respiratory failure Administered administration Adverse adverse events affected alkaline phosphatase All participants allergy Alpha alpha error angina pectoris Antibiotics appearance ARDS Arm assigned AST/ALT Baricitinib baseline beta error Bilirubin Blinding Blood Breastfeeding can be used candidate Candidates capture Cardiac arrhythmia carried change clearance clinical clinical condition clinical suspicion clinical trials Coagulation Cohort Common Terminology Criteria Comorbidity Complete completion Compliance congestive heart failure control arm Controlled trial corticoid Corticosteroids COVID19 creatinine creatinine clearance CRP D-dimer Day Deep venous thrombosis description Deterioration Dexamethasone dimer discharge discretion disease dissemination diverticulitis dose dropout rate Duration of therapy ECMO Efficacy electronic case report form element eligibility criteria Enrollment evaluate exclusion criteria expected experimental arm extracorporeal membrane oxygenation febrile neutropenia ferritin followed by form fraction Gas exchange greater HBV HCV hemodynamic instability High-flow nasal cannula HIV HIV infection ICU immobilization immunological impossibility incidence include indication Infection infection with SARS-CoV-2 Inflammatory response interfere interferon Interim interim analysis interleukin interleukin 6 interstitial pneumonia Intervention intestinal perforation Invasive mechanical ventilation investigational agent investigator jak inhibitors Jak-STAT Laboratory laboratory parameter Laboratory parameters LDH less limit limits management mechanical ventilation medical history Medicine meet Methylprednisolone Mild ARDS Mortality multi organ failure nasal nasal cannula need for oxygen neutropenia neutrophil Neutrophils Non-invasive number objective on mechanical ventilation oncological patients onset of symptom open open label oral medication organ dysfunction Organ failure outcome oxygen oxygen support PaFi participant Participants Participation pathogen Pathogens pathway Patient patients performance status performed phase Phase 1 Phase 2 Phase I phosphatase platform Pneumonia poor prognosis positive Prednisone pregnancy test pregnant prejudice Prevent progression Prophylaxis Protein protein kinase protocol Psychiatric psychiatric illness Pulmonary embolism radiological randomisation randomised randomised controlled trial randomization Randomized Randomized controlled trial receive receptor recruitment REDCap REDcap platform reduce reduced Remdesivir removal report reported required respiratory Respiratory failure Respiratory function respiratory insufficiency respiratory tract Sample size SARS-CoV-2 SARS-CoV2 SARS-CoV2 infection Secondary objectives Sepsis severe adverse event severe adverse events severe pneumonia severe respiratory failure Spain Spanish Standard of care STAT status study enrollment Study protocol supplemental oxygen requirement supplemental oxygen requirements supplementary material Support surgical surgical intervention Symptom symptomatic Tablet Therapies therapy thromboembolic disease thrombosis Tocilizumab total bilirubin Toxicity Transcription transducer Treatment treatment period Trial unstable angina use of corticosteroid Venous thrombosis Version viral endocytosis website Withdrawal worsening [DOI] 10.1186/s13063-021-05072-4 PMC 바로가기 [Article Type] Letter
Managing low‐risk febrile neutropenia in children in the time of COVID ‐19: What matters to parents and cliniciansOriginal Article Published on 2021-02-032023-06-17 Journal: Journal of paediatrics and child health [Category] MERS, SARS, [키워드] Cancer COVID‐19 febrile neutropenia home‐based care low risk [DOI] 10.1111/jpc.15330 PMC 바로가기 [Article Type] Original Article
Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paperReview Published on 2021-02-012023-07-12 Journal: Supportive Care in Cancer [Category] SARS, [키워드] Cancer COVID-19 febrile neutropenia Granulocyte colony-stimulating factor (G-CSF) Telemedicine [DOI] 10.1007/s00520-020-05906-y PMC 바로가기 [Article Type] Review